Anaïs Corma-Gómez
@anaiscorma.bsky.social
MD, PhD. Clinical researcher. Infectious Diseases. Clinical Virology, PrEP, STIs, Sexual Health. Hospital Clínico Universitario de Valencia. INCLIVA. Grupo Virología Clínica e ITS, Hospital Universitario de Valme. CIBERINFEC | she/her
🔥News: Expansion of long-acting injectable PrEP options in Europe
The European Commission has authorized Yeytuo® (lenacapavir), a twice-yearly injectable PrEP, for adults and adolescents (≥35 kg) at increased HIV‑1 risk across the EU‑27, Norway, Iceland, and Liechtenstein 👇🏼
The European Commission has authorized Yeytuo® (lenacapavir), a twice-yearly injectable PrEP, for adults and adolescents (≥35 kg) at increased HIV‑1 risk across the EU‑27, Norway, Iceland, and Liechtenstein 👇🏼
September 1, 2025 at 8:11 AM
🔥News: Expansion of long-acting injectable PrEP options in Europe
The European Commission has authorized Yeytuo® (lenacapavir), a twice-yearly injectable PrEP, for adults and adolescents (≥35 kg) at increased HIV‑1 risk across the EU‑27, Norway, Iceland, and Liechtenstein 👇🏼
The European Commission has authorized Yeytuo® (lenacapavir), a twice-yearly injectable PrEP, for adults and adolescents (≥35 kg) at increased HIV‑1 risk across the EU‑27, Norway, Iceland, and Liechtenstein 👇🏼
Reposted by Anaïs Corma-Gómez
🔴 Ya disponible el programa científico del Congreso Nacional de GeSIDA de 2025.
🔎 Descubre nuestros ponentes inaugurales, los contenidos de las sesiones plenarias y de las mesas clínicas y de ciencia básica.
➡️ www.congresogesida.es
#GeSIDA25
🔎 Descubre nuestros ponentes inaugurales, los contenidos de las sesiones plenarias y de las mesas clínicas y de ciencia básica.
➡️ www.congresogesida.es
#GeSIDA25
July 23, 2025 at 7:09 PM
🔴 Ya disponible el programa científico del Congreso Nacional de GeSIDA de 2025.
🔎 Descubre nuestros ponentes inaugurales, los contenidos de las sesiones plenarias y de las mesas clínicas y de ciencia básica.
➡️ www.congresogesida.es
#GeSIDA25
🔎 Descubre nuestros ponentes inaugurales, los contenidos de las sesiones plenarias y de las mesas clínicas y de ciencia básica.
➡️ www.congresogesida.es
#GeSIDA25
📢 JAMA (2025)
The meningococcal B vaccine (4CMenB) shows ~30% protection against gonorrhea.
🔬 Recent data identify 2 cross-reactive antigens: PorB and LOS.
🧪 Not classically immunogenic, yet may be key for future vaccines.
jamanetwork.com/journals/jam...
The meningococcal B vaccine (4CMenB) shows ~30% protection against gonorrhea.
🔬 Recent data identify 2 cross-reactive antigens: PorB and LOS.
🧪 Not classically immunogenic, yet may be key for future vaccines.
jamanetwork.com/journals/jam...
How the Meningitis Vaccine Might Protect Against Gonorrhea
This Medical News article discusses the discovery of antigens that may explain reductions in gonococcal infections following meningococcal B vaccination.
jamanetwork.com
July 3, 2025 at 7:28 AM
📢 JAMA (2025)
The meningococcal B vaccine (4CMenB) shows ~30% protection against gonorrhea.
🔬 Recent data identify 2 cross-reactive antigens: PorB and LOS.
🧪 Not classically immunogenic, yet may be key for future vaccines.
jamanetwork.com/journals/jam...
The meningococcal B vaccine (4CMenB) shows ~30% protection against gonorrhea.
🔬 Recent data identify 2 cross-reactive antigens: PorB and LOS.
🧪 Not classically immunogenic, yet may be key for future vaccines.
jamanetwork.com/journals/jam...
Reposted by Anaïs Corma-Gómez
📢 BASHH has today published national clinical guidelines on the use of doxyPEP.
This makes the UK one of the first countries globally to offer formal clinical direction on this STI prevention strategy.
🔗 Read our full statement & access the guidelines: bit.ly/4475DDK
This makes the UK one of the first countries globally to offer formal clinical direction on this STI prevention strategy.
🔗 Read our full statement & access the guidelines: bit.ly/4475DDK
June 9, 2025 at 8:13 AM
📢 BASHH has today published national clinical guidelines on the use of doxyPEP.
This makes the UK one of the first countries globally to offer formal clinical direction on this STI prevention strategy.
🔗 Read our full statement & access the guidelines: bit.ly/4475DDK
This makes the UK one of the first countries globally to offer formal clinical direction on this STI prevention strategy.
🔗 Read our full statement & access the guidelines: bit.ly/4475DDK
🔥Just published in eClinicalMedicine!
We analyzed the impact of HIV on liver stiffness (LS) dynamics after HCV cure in a large prospective cohort of 1,138 patients with F3/F4.
Key finding: PLWH had a significantly lower probability of LS normalization (≤7.2 kPa), despite SVR.
We analyzed the impact of HIV on liver stiffness (LS) dynamics after HCV cure in a large prospective cohort of 1,138 patients with F3/F4.
Key finding: PLWH had a significantly lower probability of LS normalization (≤7.2 kPa), despite SVR.
May 12, 2025 at 10:18 PM
🔥Just published in eClinicalMedicine!
We analyzed the impact of HIV on liver stiffness (LS) dynamics after HCV cure in a large prospective cohort of 1,138 patients with F3/F4.
Key finding: PLWH had a significantly lower probability of LS normalization (≤7.2 kPa), despite SVR.
We analyzed the impact of HIV on liver stiffness (LS) dynamics after HCV cure in a large prospective cohort of 1,138 patients with F3/F4.
Key finding: PLWH had a significantly lower probability of LS normalization (≤7.2 kPa), despite SVR.
Reposted by Anaïs Corma-Gómez
XV Jornadas de Enf. Emergentes
acreditadas por SNS
👉2-3 junio Auditorio @combarcelona.bsky.social
Formato híbrido
Programa definitivo e inscripciones:
uitb.cat/event/xv-jorna…
@salutpublicabcn.bsky.social#ServeisClinicsc#lokimicac#Vircellll @abbottnews.bsky.social #EnfEmergrg
acreditadas por SNS
👉2-3 junio Auditorio @combarcelona.bsky.social
Formato híbrido
Programa definitivo e inscripciones:
uitb.cat/event/xv-jorna…
@salutpublicabcn.bsky.social#ServeisClinicsc#lokimicac#Vircellll @abbottnews.bsky.social #EnfEmergrg
April 10, 2025 at 5:17 AM
XV Jornadas de Enf. Emergentes
acreditadas por SNS
👉2-3 junio Auditorio @combarcelona.bsky.social
Formato híbrido
Programa definitivo e inscripciones:
uitb.cat/event/xv-jorna…
@salutpublicabcn.bsky.social#ServeisClinicsc#lokimicac#Vircellll @abbottnews.bsky.social #EnfEmergrg
acreditadas por SNS
👉2-3 junio Auditorio @combarcelona.bsky.social
Formato híbrido
Programa definitivo e inscripciones:
uitb.cat/event/xv-jorna…
@salutpublicabcn.bsky.social#ServeisClinicsc#lokimicac#Vircellll @abbottnews.bsky.social #EnfEmergrg
📢New publication out!
🧐Can the FAST score better predict liver events after HCV cure?
We compared FAST score vs liver stiffness (LS) in 300 patients (71%PLWH)
📨Key takeaway: FAST helps, but LS alone still performs better at predicting post-SVR complications.
👇🏼👇🏼 Read more: doi.org/10.1093/ofid...
🧐Can the FAST score better predict liver events after HCV cure?
We compared FAST score vs liver stiffness (LS) in 300 patients (71%PLWH)
📨Key takeaway: FAST helps, but LS alone still performs better at predicting post-SVR complications.
👇🏼👇🏼 Read more: doi.org/10.1093/ofid...
FibroScan-AST Score vs Liver Stiffness for the Prediction of Liver Events After HCV Cure
AbstractBackground. Liver stiffness (LS) predicts liver complication occurrence in patients with hepatitis C virus (HCV) infection after sustained virologi
doi.org
April 9, 2025 at 5:39 AM
📢New publication out!
🧐Can the FAST score better predict liver events after HCV cure?
We compared FAST score vs liver stiffness (LS) in 300 patients (71%PLWH)
📨Key takeaway: FAST helps, but LS alone still performs better at predicting post-SVR complications.
👇🏼👇🏼 Read more: doi.org/10.1093/ofid...
🧐Can the FAST score better predict liver events after HCV cure?
We compared FAST score vs liver stiffness (LS) in 300 patients (71%PLWH)
📨Key takeaway: FAST helps, but LS alone still performs better at predicting post-SVR complications.
👇🏼👇🏼 Read more: doi.org/10.1093/ofid...
Reposted by Anaïs Corma-Gómez
"We condemn the censoring of science!". Powerful opening words from Diane Havlir for #croi2025
"Young researchers, we have your back. Community, we are with you"
Hell yes!!!
"Young researchers, we have your back. Community, we are with you"
Hell yes!!!
March 10, 2025 at 12:08 AM
"We condemn the censoring of science!". Powerful opening words from Diane Havlir for #croi2025
"Young researchers, we have your back. Community, we are with you"
Hell yes!!!
"Young researchers, we have your back. Community, we are with you"
Hell yes!!!
Reposted by Anaïs Corma-Gómez
Are you going to #CROI2025 in San Francisco?
We hope to see you at the rally to protect critical HIV research + programming: p2a.co/YS8dsxA
We hope to see you at the rally to protect critical HIV research + programming: p2a.co/YS8dsxA
March 7, 2025 at 1:37 PM
Are you going to #CROI2025 in San Francisco?
We hope to see you at the rally to protect critical HIV research + programming: p2a.co/YS8dsxA
We hope to see you at the rally to protect critical HIV research + programming: p2a.co/YS8dsxA
Reposted by Anaïs Corma-Gómez
📢 ¡Inscripciones abiertas!
Ya puedes registrarte en la Reunión “Cuidados diversos para necesidades diversas”, 🗓️ martes 29 de abril en la Facultad de Educación UNED
Inscripción aquí 🔗 [https://www.seisida.net/reunion2025/] #CuidadosDiversos #Educación @uneduniv.bsky.social
#Seisida2025
Ya puedes registrarte en la Reunión “Cuidados diversos para necesidades diversas”, 🗓️ martes 29 de abril en la Facultad de Educación UNED
Inscripción aquí 🔗 [https://www.seisida.net/reunion2025/] #CuidadosDiversos #Educación @uneduniv.bsky.social
#Seisida2025
February 10, 2025 at 10:08 AM
📢 ¡Inscripciones abiertas!
Ya puedes registrarte en la Reunión “Cuidados diversos para necesidades diversas”, 🗓️ martes 29 de abril en la Facultad de Educación UNED
Inscripción aquí 🔗 [https://www.seisida.net/reunion2025/] #CuidadosDiversos #Educación @uneduniv.bsky.social
#Seisida2025
Ya puedes registrarte en la Reunión “Cuidados diversos para necesidades diversas”, 🗓️ martes 29 de abril en la Facultad de Educación UNED
Inscripción aquí 🔗 [https://www.seisida.net/reunion2025/] #CuidadosDiversos #Educación @uneduniv.bsky.social
#Seisida2025
Reposted by Anaïs Corma-Gómez
2024 Anal Cancer Screening Guidelines: Analysis of Clinical Performance and HRA Utilization in a large Cohort of Persons with HIV
« … all triage and co-testing strategies outperformed cytology alone. »
#IDsky #HIVsky
academic.oup.com/cid/advance-...
« … all triage and co-testing strategies outperformed cytology alone. »
#IDsky #HIVsky
academic.oup.com/cid/advance-...
February 5, 2025 at 12:56 PM
2024 Anal Cancer Screening Guidelines: Analysis of Clinical Performance and HRA Utilization in a large Cohort of Persons with HIV
« … all triage and co-testing strategies outperformed cytology alone. »
#IDsky #HIVsky
academic.oup.com/cid/advance-...
« … all triage and co-testing strategies outperformed cytology alone. »
#IDsky #HIVsky
academic.oup.com/cid/advance-...
Reposted by Anaïs Corma-Gómez
Decrease In California’s STIs Followed Early Real-World Adoption Of DoxyPEP
#IDSky
#STI
#PublicHealth
jamanetwork.com/journals/jam...
#IDSky
#STI
#PublicHealth
jamanetwork.com/journals/jam...
Doxycycline Postexposure Prophylaxis and Sexually Transmitted Infection Trends
This study assesses the association of citywide doxycycline postexposure prophylaxis guideline release with reported chlamydia, gonorrhea, and early syphilis cases in men who have sex with men and in ...
jamanetwork.com
January 7, 2025 at 7:25 PM
Decrease In California’s STIs Followed Early Real-World Adoption Of DoxyPEP
#IDSky
#STI
#PublicHealth
jamanetwork.com/journals/jam...
#IDSky
#STI
#PublicHealth
jamanetwork.com/journals/jam...
Reposted by Anaïs Corma-Gómez
Research analysing #European survey data from 113,884 men who have sex with men (MSM) indicates that
🔹 most MSM have a basic understanding of #viral #hepatitis
🔸 only 44% report having been vaccinated against both hepatitis A & B
#publichealth #sexualhealth 😷💉⚕️
www.eurekalert.org/news-release...
🔹 most MSM have a basic understanding of #viral #hepatitis
🔸 only 44% report having been vaccinated against both hepatitis A & B
#publichealth #sexualhealth 😷💉⚕️
www.eurekalert.org/news-release...
Men who have sex with men in Europe still vulnerable to hepatitis A and B, highlighting need for public health action and support
Research analysing European survey data from 113,884 men who have sex with men (MSM) and published in Eurosurveillance indicates that while most MSM have a basic understanding of viral hepatitis, only...
www.eurekalert.org
November 8, 2024 at 12:35 PM
Research analysing #European survey data from 113,884 men who have sex with men (MSM) indicates that
🔹 most MSM have a basic understanding of #viral #hepatitis
🔸 only 44% report having been vaccinated against both hepatitis A & B
#publichealth #sexualhealth 😷💉⚕️
www.eurekalert.org/news-release...
🔹 most MSM have a basic understanding of #viral #hepatitis
🔸 only 44% report having been vaccinated against both hepatitis A & B
#publichealth #sexualhealth 😷💉⚕️
www.eurekalert.org/news-release...
Reposted by Anaïs Corma-Gómez
US based STOMP trial of tecovirimat (tpoxx) for clade 2 mpox fails to demonstrate efficacy benefit. Just as it did not in PALM 007 in clade 1 mpox in DRC.
There is no known treatment for mpox
Vaccination is the key control strategy and more research is needed.
pubmed.ncbi.nlm.nih.gov/38190312/
Early Tecovirimat Treatment for Mpox Disease Among People With HIV - PubMed
Results of this cohort study support starting tecovirimat in all PWH as soon as an mpox diagnosis is suspected. Additional research is warranted to confirm these findings.
pubmed.ncbi.nlm.nih.gov
December 10, 2024 at 11:00 PM
US based STOMP trial of tecovirimat (tpoxx) for clade 2 mpox fails to demonstrate efficacy benefit. Just as it did not in PALM 007 in clade 1 mpox in DRC.
There is no known treatment for mpox
Vaccination is the key control strategy and more research is needed.
pubmed.ncbi.nlm.nih.gov/38190312/
Reposted by Anaïs Corma-Gómez
Infectious diseases is not only about the latest trials and big cohort studies.
So, here is a list of my favourite pieces that you might missed from The Lancet Infectious Diseases in 2024 that reflect on the field at large, in no specific order.
#IDSky
So, here is a list of my favourite pieces that you might missed from The Lancet Infectious Diseases in 2024 that reflect on the field at large, in no specific order.
#IDSky
December 20, 2024 at 4:52 PM
Infectious diseases is not only about the latest trials and big cohort studies.
So, here is a list of my favourite pieces that you might missed from The Lancet Infectious Diseases in 2024 that reflect on the field at large, in no specific order.
#IDSky
So, here is a list of my favourite pieces that you might missed from The Lancet Infectious Diseases in 2024 that reflect on the field at large, in no specific order.
#IDSky
Reposted by Anaïs Corma-Gómez
Three must read papers for PhD students. #scisky #PhD #science #research #academicsky
1. The importance of stupidity in scientific research
Open Access
journals.biologists.com/jcs/article/...
1. The importance of stupidity in scientific research
Open Access
journals.biologists.com/jcs/article/...
November 24, 2024 at 1:54 PM
Three must read papers for PhD students. #scisky #PhD #science #research #academicsky
1. The importance of stupidity in scientific research
Open Access
journals.biologists.com/jcs/article/...
1. The importance of stupidity in scientific research
Open Access
journals.biologists.com/jcs/article/...
Reposted by Anaïs Corma-Gómez
Science’s 2024 Breakthrough of the Year is lenacapavir, an injectable drug that demonstrated remarkable success at preventing HIV infection with one shot every 6 months.
Learn more about this year's #BOTY and other big advances in science: scim.ag/3BrCtUn
Learn more about this year's #BOTY and other big advances in science: scim.ag/3BrCtUn
December 12, 2024 at 7:02 PM
Science’s 2024 Breakthrough of the Year is lenacapavir, an injectable drug that demonstrated remarkable success at preventing HIV infection with one shot every 6 months.
Learn more about this year's #BOTY and other big advances in science: scim.ag/3BrCtUn
Learn more about this year's #BOTY and other big advances in science: scim.ag/3BrCtUn
📢 Happy to share our new study: In patients who live with chronic HCV infection and advanced liver fibrosis/cirrhosis, HIV coinfection does not reduce overall survival after SVR.
academic.oup.com/cid/advance-...
@GEHEP @EVirologia @cidjournal.bsky.social
academic.oup.com/cid/advance-...
@GEHEP @EVirologia @cidjournal.bsky.social
No Impact of Human Immunodeficiency Virus (HIV) Coinfection on Mortality in Patients With Hepatitis C Virus Infection After Sustained Virological Response
In patients with chronic HCV infection, the survival of people with HIV after sustained virological response is still not well established. This study demo
academic.oup.com
December 3, 2024 at 7:10 AM
📢 Happy to share our new study: In patients who live with chronic HCV infection and advanced liver fibrosis/cirrhosis, HIV coinfection does not reduce overall survival after SVR.
academic.oup.com/cid/advance-...
@GEHEP @EVirologia @cidjournal.bsky.social
academic.oup.com/cid/advance-...
@GEHEP @EVirologia @cidjournal.bsky.social
Reposted by Anaïs Corma-Gómez
Is it time to (finally) stop screening and testing of asymptomatic PreP users for NG and CT ?
"Treatment of asymptomatic chlamydia and gonorrhoea drives antibiotic consumption in PrEP cohorts"
#IDSky #HIVSky
sti.bmj.com/content/earl...
"Treatment of asymptomatic chlamydia and gonorrhoea drives antibiotic consumption in PrEP cohorts"
#IDSky #HIVSky
sti.bmj.com/content/earl...
Treatment of asymptomatic chlamydia and gonorrhoea drives antibiotic consumption in PrEP cohorts
Excessive consumption of antimicrobials drives antimicrobial resistance (AMR).1 The frequent emergence of AMR in subpopulations of men who have sex with men (MSM), such as HIV pre-exposure prophylaxis...
sti.bmj.com
December 1, 2024 at 7:01 PM
Is it time to (finally) stop screening and testing of asymptomatic PreP users for NG and CT ?
"Treatment of asymptomatic chlamydia and gonorrhoea drives antibiotic consumption in PrEP cohorts"
#IDSky #HIVSky
sti.bmj.com/content/earl...
"Treatment of asymptomatic chlamydia and gonorrhoea drives antibiotic consumption in PrEP cohorts"
#IDSky #HIVSky
sti.bmj.com/content/earl...
Reposted by Anaïs Corma-Gómez
🆕️🔥 #JAMA
Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel #idsky #hivsky #tbsky #worldaidsday #medsky
jamanetwork.com/journals/jam...
Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel #idsky #hivsky #tbsky #worldaidsday #medsky
jamanetwork.com/journals/jam...
IAS-USA Recommendations: Antiretrovirals for Treatment and Prevention of HIV in Adults
This Special Communication from the International Antiviral Society–USA provides updated 2024 recommendations for HIV treatment and clinical management and HIV prevention.
jamanetwork.com
December 2, 2024 at 3:54 PM
🆕️🔥 #JAMA
Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel #idsky #hivsky #tbsky #worldaidsday #medsky
jamanetwork.com/journals/jam...
Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel #idsky #hivsky #tbsky #worldaidsday #medsky
jamanetwork.com/journals/jam...